Menu
2014 Session

Budget Amendments - HB30 (Member Request)

View Budget Item
View Budget Item amendments

Chief Patron: Albo
Creation of Drug Therapy Program

Item 37 #7h

Item 37 #7h

First Year - FY2015 Second Year - FY2016
Judicial Department
Supreme Court FY2015 $500,000 FY2016 $500,000 GF

Language
Page 21, line 40, strike "$29,652,561" and insert "$30,152,561".
Page 21, line 40, strike "$29,904,609" and insert "$30,404,609".
Page 23, after line 8, insert:
"K.1.  Out of this appropriation, $500,000 the first year and $500,000 the second year from the general fund shall be allocated by the Office of the Executive Secretary of the Supreme Court to existing drug treatment courts (as defined in § 18.2-254.1, Code of Virginia) for the purpose of launching an addiction treatment pilot program that utilizes FDA-approved pharmacotherapies to treat dependence on opioids, alcohol, or both.  These pharmacotherapies shall be limited to drugs that are non-opioid, non-addictive, and long acting antagonistic.  These pharmacotherapies shall be further limited by the terms outlined within the evaluation plan developed in accordance with the following guidelines.
2. In conducting the pilot program, the existing drug treatment courts shall collaborate with any agency authorized to receive funds from the Drug Offender Assessment and Treatment Fund (as defined in § 18.2-251.02, Code of Virginia) or deemed necessary by the Supreme Court.
3. Not later than sixty days after the effective date of this section, the Supreme Court shall select a nationally recognized criminal justice institute with extensive experience in the evaluation of criminal justice and substance abuse projects to develop an evaluation plan for the pilot program.  The evaluation plan shall include performance measures that reflect the purpose of the pilot program, which is to assist participants in addressing their dependence on opioids, alcohol, or both, by maintaining abstinence from the use of those substances and reducing recidivism.  
4. Before any person may be enrolled as a participant in the pilot program, the evaluation plan developed by the research institute shall be put into place in every drug treatment court involved in the program.
5. Once the evaluation plan has been put into place, the certified drug treatment court programs shall select persons who are offenders within the criminal justice system to be participants in the pilot program.  To be selected, a person must meet the legal and clinical eligibility criteria for the certified drug treatment court program, be an active participant in the program, and freely choose to participate in the pilot program as a condition of his or her sentencing.  
6. After being enrolled in the pilot program, the participant shall comply with all requirements of the drug treatment court and the pilot program itself.
7. The research institute selected by the Supreme Court under (3) shall prepare a report of findings obtained from the pilot program.  This report shall include data derived from the drug testing and performance measures used in the pilot program.  In preparing the report, the research institute shall obtain assistance from the Executive Secretary of the Supreme Court.  
8.  This report shall be completed and submitted to the Supreme Court not later than six months after the conclusion of the pilot program.


Explanation
(This amendment directs existing drug treatment courts to launch a voluntary pilot program that utilizes specific pharmacotherapies to treat dependence on opioids, alcohol, or both as a condition of sentencing. Furthermore, it directs the Supreme Court to study the effectiveness of these pharmacotherapies in maintaining abstinence from the use of those substances and reducing recidivism. The amendment requires general fund dollars for this pilot program.)